Wedelolactone Mitigates Alcoholic Steatohepatitis via Modulating the TLR4/MyD88/NF-κB Pathway
Background. Wedelolactone (WEL) has demonstrated anti-inflammatory properties. However, the therapeutic effect and underlying mechanisms of WEL against alcoholic steatohepatitis (ASH) remain unclear. This study aimed to investigate these aspects using animal and cell models. Methods and Results. The...
Saved in:
Main Authors: | Tao Jiang, Bingde Hu, Yongxia Li, Shuihong Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2024/9185668 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multiple low-dose radiation ameliorates type-2 diabetes mellitus via gut microbiota modulation to activate TLR4/MyD88/NF-κB pathway
by: Lijing Qin, et al.
Published: (2025-02-01) -
EZH2 Regulates Lipopolysaccharide-Induced Periodontal Ligament Stem Cell Proliferation and Osteogenesis through TLR4/MyD88/NF-κB Pathway
by: Pengcheng Wang, et al.
Published: (2021-01-01) -
Protective Effects of Celastrol on Diabetic Liver Injury via TLR4/MyD88/NF-κB Signaling Pathway in Type 2 Diabetic Rats
by: Li-ping Han, et al.
Published: (2016-01-01) -
EGCG Maintains Th1/Th2 Balance and Mitigates Ulcerative Colitis Induced by Dextran Sulfate Sodium through TLR4/MyD88/NF-κB Signaling Pathway in Rats
by: Xue Bing, et al.
Published: (2017-01-01) -
Momordica Charantia Polysaccharides Attenuates MPP+-Induced Injury in Parkinson’s Disease Mice and Cell Models by Regulating TLR4/MyD88/NF-κB Pathway
by: Dengjun Guo, et al.
Published: (2021-01-01)